U.S. markets open in 1 hour 31 minutes

CEL-SCI Corporation (CVM)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
16.15+0.02 (+0.12%)
At close: 4:00PM EDT

16.40 +0.25 (1.55%)
Pre-Market: 7:42AM EDT

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected


Previous Close16.13
Bid16.15 x 1300
Ask16.89 x 1100
Day's Range15.55 - 18.87
52 Week Range10.37 - 40.91
Avg. Volume1,142,670
Market Cap654.548M
Beta (5Y Monthly)2.09
PE Ratio (TTM)N/A
EPS (TTM)-0.88
Earnings DateFeb 16, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateAug 28, 1996
1y Target Est19.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • We Think CEL-SCI (NYSEMKT:CVM) Can Afford To Drive Business Growth
    Simply Wall St.

    We Think CEL-SCI (NYSEMKT:CVM) Can Afford To Drive Business Growth

    Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

  • Biotech CEL-SCI Needs More Base Building

    Biotech CEL-SCI Needs More Base Building

    During Friday's "Lightning Round" segment of Mad Money, one caller asked Jim Cramer about the biotech firm CEL-SCI Corp : "I think this one is good," responded Cramer. In this daily bar chart of CVM, below, we can see that prices traded sideways in the $18-$12 area from late April to late January before exploding on the upside. Prices soared sharply to around $40 in a few days and since then prices have been slowly declining back to the breakout level or the top end of the consolidation pattern.

  • Zacks Small Cap Research

    CVM: 1Q:21 Financial Update

    By John Vandermosten, CFA NYSE:CVM First Quarter Fiscal Year 2021 Operational and Financial Results CEL-SCI Corporation (NYSE:CVM) posted a press release and filed its 10-Q for its first quarter of fiscal year 2021 in mid-February. Since our previous report update on January 6, CEL-SCI has continued to monitor its contract research organization’s progress analyzing locked data for the IT-MATTERS